Skip to main content

Advertisement

Table 2 End of treatment and early virological response in both groups

From: Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial

Treatment group End of Treatment Response (6 months) Total Sig
   non-ETR p-ETR c-ETR   
Spirulina Count 24 2 4 30 0.12
  % within Treatment group 80% 6.7% 13.3% 100%  
Silymarin Count 28 0 1 29  
  % within Treatment group 96.6% 0% 3.4% 100%  
Treatment group Early Virological Response (3 months) Total Sig
   non-EVR p-EVR c-EVR   
Spirulina Count 27 2 1 30 0.22
  % within Treatment group 90% 6.7% 3.3% 100%  
Silymarin Count 29 0 0 29  
  % within Treatment group 100% 0% 0% 100%